Insulet (PODD) Other Non Operating Income (2011 - 2026)
Insulet's (PODD) quarterly Other Non Operating Income came in at $700000.0 in Q1 2026, up 101.77% YoY from $346926.0 in Q1 2025, and down 77.42% on a QoQ basis from $3.1 million in Q4 2025.
Insulet (PODD) Other Non Operating Income (2011 - 2026) Analysis & Trends
Insulet (PODD) has 16 years of Other Non Operating Income data on file, last reported at $700000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 101.77% year-over-year to $700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108.0 million (down 123.14% YoY) and the FY2025 annual result came in at $14.3 million, up 360.0% from the prior year.
- Other Non Operating Income retreated to $700000.0 in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $12.1 million in Q3 2025 to a low of -$123.9 million in Q2 2025.
- A 5-year average of -$10.4 million and a median of -$200000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income sank 585.71% — and 2025, when it surged 455.88%.
- Tracing PODD's Other Non Operating Income over 5 years: stood at $1.5 million in 2022, then increased by 26.67% to $1.9 million in 2023, then plunged by 389.47% to -$5.5 million in 2024, then surged by 156.36% to $3.1 million in 2025, then plunged by 77.42% to $700000.0 in 2026.
- The last three Other Non Operating Income figures came in at $700000.0 (Q1 2026), $3.1 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 Mn |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 12.10 Mn |
| Jun 30, 2025 | -123.90 Mn |
| Mar 31, 2025 | -39.50 Mn |
| Dec 31, 2024 | -5.50 Mn |
| Sep 30, 2024 | -3.40 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | -40.90 Mn |
| Sep 30, 2021 | -700,000.00 |
| Jun 30, 2021 | -40.10 Mn |
| Mar 31, 2021 | -2.60 Mn |